Extended trial tests growth drug for kids with rare genetic condition
NCT ID NCT07393373
Summary
This study continues testing an experimental drug called infigratinib in children with hypochondroplasia, a genetic condition that causes short stature. It follows children who completed a previous study to monitor the drug's long-term safety and whether it helps with growth and development. The research aims to understand if this treatment can better manage the condition over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOCHONDROPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Astrid Lindgren Children's Hospital
Solna, 17164, Sweden
-
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants
Toulouse, 31059, France
-
Children's Hospital of Eastern Ontario Research Institute
Ottawa, Ontario, K1H 8L1, Canada
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Childrens Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Glasgow Clinical Research Facility, Queen Elizabeth University Hospital
Glasgow, Scotland, G51 4TF, United Kingdom
-
Haukeland University Hospital
Bergen, 5021, Norway
-
Hospital Pediátrico de Coimbra
Coimbra, 3000-602, Portugal
-
Hôpital Femme Mère Enfant
Bron, 69677, France
-
Hôpital Universitaire Necker-Enfants Malades
Paris, 75015, France
-
Johns Hopkins School of Medicine
Baltimore, Maryland, 21287, United States
-
KK Women's and Children's Hospital
Singapore, 229899, Singapore
-
London Health Sciences Centre - Children's Hospital of Western Ontario
London, Ontario, N6C 2R5, Canada
-
Manchester University
Manchester, England, M13 9WL, United Kingdom
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
Paediatric Clinical Research Unit at Osla University Hospital
Oslo, 0372, Norway
-
Sheffield Children's Hospital
Sheffield, England, S10 2TH, United Kingdom
-
The Portland Hospital for Women and Children
London, England, W1W 5AH, United Kingdom
-
UCA Hospital MiKS
Vitoria-Gasteiz, 01010, Spain
-
UCSF Benioff Children's Hospital
Oakland, California, 94609, United States
-
University of Missouri
Columbia, Missouri, 65201, United States
-
University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic
Madison, Wisconsin, 53705, United States
-
Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, H3T 1C5, Canada
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.